MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Sarepta Therapeutics DIO Ratio 2011-2026 | SRPT
Annual DIO Ratio Sarepta Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.11 K | 1.34 K | 4.15 K | 36 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36 K | 1.11 K | 10.6 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M |  Canada |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.81 | 1.31 % | $ 4.42 M |  China |
 |
Axsome Therapeutics
AXSM
|
168 | $ 167.61 | -4.09 % | $ 8.34 B |  USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
BioMarin Pharmaceutical
BMRN
|
736 | $ 63.02 | 0.15 % | $ 12 B | USA |
 |
CASI Pharmaceuticals
CASI
|
47.4 | $ 0.79 | 4.29 % | $ 108 M | USA |
 |
Catalyst Biosciences
CBIO
|
410 | $ 12.71 | 10.81 % | $ 837 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.72 | 2.08 % | $ 4.55 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | USA |